AI-generated sensors open new paths for early cancer detection
January 6, 2026
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Nanomaterial crosses blood-brain barrier, targets harmful inflammation after most common type of stroke
The B3 GEL System maintains biomechanical separation throughout the essential healing window.
The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.
Stereotaxis (NYSE:STXS) has won FDA approval for its robotically navigated MAGiC ablation catheter, offering a minimally invasive option for patients who otherwise might not be eligible for cardiac ablation to treat complex and critical heart rhythm disorders.
W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.
Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced today that it plans to launch a new, FDA-cleared artificial heart accessory.